allylamine has been researched along with Fatty Liver, Nonalcoholic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Changchien, C; Chen, J; Hamilton, G; Le, TA; Loomba, R; Middleton, MS; Sirlin, CB; Tang, A | 1 |
| Brenner, D; Changchien, C; Chen, J; Cohen, BL; Kono, Y; Le, TA; Loomba, R; Patton, H; Peterson, MR; Sirlin, C | 1 |
2 trial(s) available for allylamine and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Cross-sectional and longitudinal evaluation of liver volume and total liver fat burden in adults with nonalcoholic steatohepatitis.
Topics: Adipose Tissue; Aged; Allylamine; Anticholesteremic Agents; Colesevelam Hydrochloride; Cross-Sectional Studies; Double-Blind Method; Female; Humans; Image Interpretation, Computer-Assisted; Liver; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Organ Size | 2015 |
Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial.
Topics: Allylamine; Anticholesteremic Agents; Colesevelam Hydrochloride; Double-Blind Method; Fatty Liver; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Prospective Studies | 2012 |